Canada markets close in 31 minutes

Lexaria Bioscience Corp. (LXRP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3764-0.0236 (-5.90%)
As of 3:05PM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 533.72M
Enterprise Value 333.83M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)89.70
Price/Book (mrq)10.46
Enterprise Value/Revenue 389.98
Enterprise Value/EBITDA 6-8.13

Trading Information

Stock Price History

Beta (5Y Monthly) 1.99
52-Week Change 3-54.02%
S&P500 52-Week Change 316.25%
52 Week High 31.0000
52 Week Low 30.2200
50-Day Moving Average 30.3285
200-Day Moving Average 30.3414

Share Statistics

Avg Vol (3 month) 3105.78k
Avg Vol (10 day) 372.03k
Shares Outstanding 589.59M
Float 73.79M
% Held by Insiders 119.28%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 211:10
Last Split Date 3Dec. 15, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 30, 2019
Most Recent Quarter (mrq)May 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-1,135.62%

Management Effectiveness

Return on Assets (ttm)-78.74%
Return on Equity (ttm)-135.74%

Income Statement

Revenue (ttm)375.93k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)35.90%
Gross Profit (ttm)192.53k
Net Income Avi to Common (ttm)-4.3M
Diluted EPS (ttm)-0.0530
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.05M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)28.76k
Total Debt/Equity (mrq)0.90
Current Ratio (mrq)27.79
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-2.72M
Levered Free Cash Flow (ttm)-1.06M